Renaissance Technologies
PPBT

Renaissance Technologies’s Purple Biotech PPBT Stock Holding History

Renaissance Technologies’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-251
Closed -$198K – 4496
2022
Q1 		$198K Buy
+251
New +$162K ﹤0.01% 3652
2021
Q2 		– Sell
-1,095
Closed -$905K – 3710
2021
Q1 		$905K Buy
1,095
+450
+70% +$420K ﹤0.01% 2654
2020
Q4 		$491K Buy
+645
New +$544K ﹤0.01% 2821
2020
Q2 		– Sell
-189
Closed -$116K – 3697
2020
Q1 		$116K Buy
+189
New +$232K ﹤0.01% 3199

Other funds holding PPBT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Renaissance Technologies's PPBT Position: Q2 2022 in Review

Renaissance Technologies sold out of Purple Biotech (PPBT) in Q2 2022, closing a stake of 251 shares — an estimated $198K sold.

Renaissance Technologies first reported a position in PPBT in Q1 2020 and held it in 4 quarters. The position peaked at $905K in Q1 2021. 12 funds tracked by Wall St. Rank hold PPBT as of Q2 2022.

  • Renaissance Technologies reported no remaining Purple Biotech position as of Q2 2022 after selling out during the quarter.
  • Renaissance Technologies sold 251 Purple Biotech shares in Q2 2022, an estimated $198K.
  • Renaissance Technologies first reported a position in Purple Biotech in Q1 2020 and held it in 4 quarters.
  • Renaissance Technologies's Purple Biotech position peaked at $905K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2022.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.